financetom
Business
financetom
/
Business
/
BWX Technologies Wins Phase 2 Contract of Wyoming's Microreactor Evaluation Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BWX Technologies Wins Phase 2 Contract of Wyoming's Microreactor Evaluation Program
Jun 18, 2024 1:06 AM

03:46 AM EDT, 06/18/2024 (MT Newswires) -- BWX Technologies ( BWXT ) said late Monday it won the second phase of a contract with the Wyoming Energy Authority to evaluate the potential use of small-scale nuclear reactors in the state.

The company previously worked in the first phase of the program where it defined the requirements for nuclear applications and performed microreactor system engineering works. The second phase involves completing a conceptual design, regulatory engagement plan and a microreactor fleet model, the company said.

The program has an aggregate value of $20 million, according to BWX.

The company expects to complete the second phase by Q3 2025.

Price: 91.08, Change: -0.13, Percent Change: -0.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Civeo to Acquire Four Australian Villages for $66.7 Million
Civeo to Acquire Four Australian Villages for $66.7 Million
Feb 19, 2025
09:25 AM EST, 02/19/2025 (MT Newswires) -- Civeo ( CVEO ) said Wednesday that it has agreed to acquire from a private seller four villages with 1,340 rooms in the coal producing Bowen Basin in Queensland, Australia. Under the terms of the deal, Civeo ( CVEO ) said it will acquire the assets and customer contracts for 105 million Australian...
Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide
Amneal Pharmaceuticals Launching Mesalamine, Gets US FDA Approval for Lenalidomide
Feb 19, 2025
09:28 AM EST, 02/19/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Wednesday that it will launch mesalamine 800 milligram delayed-release tablets to treat moderately active ulcerative colitis in adults. The company also said it has received approval from the US Food and Drug Administration for an abbreviated new drug application for lenalidomide capsules, which are used to treat...
Trump Media, Rumble sue Brazilian supreme court justice
Trump Media, Rumble sue Brazilian supreme court justice
Feb 19, 2025
WASHINGTON/SAO PAULO (Reuters) - U.S. President Donald Trump's Trump Media & Technology Group ( DJT ) and video-sharing platform Rumble sued a Brazilian Supreme Court justice over accusations of illegal censorship on Wednesday. The case comes as the judge, Alexandre de Moraes, weighs charges brought on Tuesday alleging former President Jair Bolsonaro led a plot to overthrow Brazil's government and...
Nicknames bloom in China's tech renaissance
Nicknames bloom in China's tech renaissance
Feb 19, 2025
* Surge in Chinese tech stocks captures analysts' imagination * Catchy monikers rival 'Magnificent Seven' in the US * AI startup DeepSeek fuels buzz around technology companies By Tom Westbrook and Samuel Shen SINGAPORE/SHANGHAI, Feb 19 (Reuters) - Six Little Dragons, Seven Sisters and the Terrific Ten. These are some of the nicknames being bestowed on China's cast of home-grown...
Copyright 2023-2026 - www.financetom.com All Rights Reserved